Nelmastobart in Combination With Trifluridine/ Tipiracil and Bevacizumab in Metastatic/ Recurrent Colorectal Cancer

Clinical trial NCT06873763 · RECRUITING

Trial details

NCT number: NCT06873763
Sponsor: STCube, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer (CRC)Recurrent Colorectal Cancer

Start date: 2025-06-09
Primary completion: 2025-12-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.